共 36 条
Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway
被引:56
作者:
Kim, Seul Gi
[1
,2
]
Kim, Jae-Ryong
[2
,3
]
Choi, Hyoung Chul
[1
,2
]
机构:
[1] Yeungnam Univ, Coll Med, Dept Pharmacol, 170 Hyunchung Ro, Daegu 42415, South Korea
[2] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea
[3] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Daegu, South Korea
基金:
新加坡国家研究基金会;
关键词:
AMPK;
MLCK;
p-MLC;
quercetin;
vasorelaxation;
VSMC;
VASCULAR SMOOTH-MUSCLE;
LIGHT-CHAIN KINASE;
CALCIUM-CHANNELS;
UPSTREAM KINASE;
BLOOD-PRESSURE;
RAT AORTA;
CELLS;
APOPTOSIS;
MECHANISM;
PROLIFERATION;
D O I:
10.1089/jmf.2017.4052
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
The vascular tone plays an important role in blood pressure and flow. It is influenced by the contraction of vascular smooth muscle cells (VSMCs), which in turn is regulated by the balance between the myosin light chain kinase (MLCK) and the phosphorylated myosin light chain (p-MLC). Quercetin is a common flavonoid which is found in many fruits and red wine. Although quercetin has been widely reported to be involved in cell proliferation, migration, and apoptosis in VSMCs, it has not yet been demonstrated whether quercetin is related to vasocontraction, a function regulated by the AMP-activated protein kinase (AMPK) signaling pathway. Accordingly, the aim of this study is to investigate the molecular mechanism through which the quercetin-activated LKB1-AMPK signaling pathway regulates the contraction of VSMCs. In cultured VSMCs, quercetin activated AMPK in a dose- and time-dependent manner. Quercetin inhibited the phenylephrine (PE)-induced expression of MLCK and p-MLC through the LKB1-AMPK signaling pathway and decreased the mRNA level of MLCK. Adenovirus-AMPK DN 1 and AMPK DN 2-transduced VSMCs displayed higher p-MLC expression. Moreover, quercetin inhibited the PE-mediated contraction in rat aorta. These data suggest that the quercetin-activated LKB1-AMPK signaling pathway regulates VSMC contraction by inhibiting MLCK and p-MLC; hence, it may be a therapeutic intervention for the treatment of cardiovascular disorders such as atherosclerosis and hypertension.
引用
收藏
页码:146 / 153
页数:8
相关论文